NUVOLI, Susanna Maria Francesca
 Distribuzione geografica
Continente #
NA - Nord America 16.240
AS - Asia 8.762
EU - Europa 6.147
SA - Sud America 5.853
AF - Africa 295
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 35
Totale 37.374
Nazione #
US - Stati Uniti d'America 15.912
BR - Brasile 5.241
SG - Singapore 3.792
CN - Cina 2.730
UA - Ucraina 2.048
SE - Svezia 1.035
HK - Hong Kong 945
DE - Germania 929
IT - Italia 746
FI - Finlandia 391
GB - Regno Unito 302
VN - Vietnam 235
AR - Argentina 231
FR - Francia 166
TR - Turchia 160
RU - Federazione Russa 132
IN - India 118
BD - Bangladesh 117
MX - Messico 116
CA - Canada 115
UZ - Uzbekistan 98
IQ - Iraq 95
ZA - Sudafrica 92
EC - Ecuador 81
CO - Colombia 77
VE - Venezuela 68
MA - Marocco 64
KR - Corea 58
PK - Pakistan 57
CZ - Repubblica Ceca 51
JP - Giappone 49
BE - Belgio 46
PL - Polonia 43
PY - Paraguay 40
AU - Australia 36
ES - Italia 36
TN - Tunisia 36
NL - Olanda 35
AT - Austria 34
UY - Uruguay 34
ID - Indonesia 33
AZ - Azerbaigian 31
CL - Cile 31
EU - Europa 29
PE - Perù 29
AE - Emirati Arabi Uniti 28
JO - Giordania 28
IL - Israele 23
RO - Romania 23
KE - Kenya 20
KZ - Kazakistan 20
DO - Repubblica Dominicana 19
DZ - Algeria 19
EG - Egitto 18
LT - Lituania 18
NP - Nepal 18
AL - Albania 17
BO - Bolivia 17
HN - Honduras 17
JM - Giamaica 17
KG - Kirghizistan 17
SA - Arabia Saudita 14
SN - Senegal 13
IE - Irlanda 11
IR - Iran 11
LB - Libano 11
PA - Panama 11
BY - Bielorussia 10
OM - Oman 10
GE - Georgia 9
RS - Serbia 9
BG - Bulgaria 8
CR - Costa Rica 8
BH - Bahrain 7
GA - Gabon 7
GR - Grecia 7
PH - Filippine 7
PS - Palestinian Territory 7
BA - Bosnia-Erzegovina 6
BN - Brunei Darussalam 6
MD - Moldavia 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
AO - Angola 5
CH - Svizzera 5
PT - Portogallo 5
QA - Qatar 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
CI - Costa d'Avorio 4
DK - Danimarca 4
GT - Guatemala 4
HU - Ungheria 4
MK - Macedonia 4
GH - Ghana 3
LU - Lussemburgo 3
LV - Lettonia 3
MN - Mongolia 3
Totale 37.326
Città #
Dallas 6.265
Chandler 2.105
Singapore 1.925
Jacksonville 1.291
Hong Kong 936
Princeton 689
Dearborn 664
Nanjing 583
Beijing 513
Ashburn 401
New York 355
São Paulo 353
Wilmington 287
Boardman 281
Sassari 242
Shanghai 233
Nanchang 226
Los Angeles 192
Rio de Janeiro 164
Belo Horizonte 153
Shenyang 142
Munich 138
Tianjin 120
Ann Arbor 114
Brasília 110
Woodbridge 98
Ho Chi Minh City 97
Jiaxing 94
Santa Clara 93
Hebei 91
Tashkent 87
Changsha 76
Curitiba 71
Porto Alegre 64
San Francisco 61
Seoul 58
Buffalo 57
Helsinki 56
Goiânia 55
Salvador 54
Turku 54
Campinas 52
Guarulhos 49
Hangzhou 49
Kunming 47
Brussels 45
Manaus 45
Tokyo 43
Brno 41
Johannesburg 41
Toronto 41
Cagliari 40
Fortaleza 40
Norwalk 40
Baghdad 38
Chicago 38
London 38
Sorocaba 38
Warsaw 37
Jinan 36
Stockholm 36
Hanoi 35
Montreal 35
Istanbul 34
Joinville 34
Buenos Aires 33
Guangzhou 33
Brooklyn 32
Contagem 32
Baku 31
Denver 31
Dhaka 30
Recife 30
Ribeirão Preto 30
São José dos Campos 30
Poplar 28
Ankara 27
Betim 27
Caxias do Sul 27
Rome 27
The Dalles 27
Zhengzhou 27
Amman 26
Chennai 26
Columbus 26
Council Bluffs 26
Juiz de Fora 26
Mexico City 26
Uberlândia 26
Asunción 25
Atlanta 25
Guayaquil 25
Izmir 25
Montevideo 25
Osasco 25
Boston 24
Frankfurt am Main 24
Ipatinga 24
Lima 24
Milan 23
Totale 21.573
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 317
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 291
123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders 262
123I-FP-CIT SPECT: a new diagnostic method for Parkinson Disease 251
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. 246
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). 233
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. 233
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) 224
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) 222
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. 222
123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders 210
123I Ioflupane SPECT in the differential diagnosis of Lewy bodies Dementia 210
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease 207
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors 207
123I-FP-CIT brain SPECT data by means of a support vector machine classifier (SVM) to diagnose Parkinson’s disease. 206
β-Endorphin and Cortisol Levels in Plasma and CSF Following Acute Experimental Spinal Traumas 205
123I FP-CIT SPECT in early Parkinson’s disease 205
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage. 204
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 197
99mTc-Tetrofosmin Pinhole-SPECT (P-SPECT) and Radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging 192
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders 187
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 185
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 181
99mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis 176
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 174
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage 169
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 166
99mTc HM-PAO Brain Spect Qualitative and Quantitative Analyses (QLA/QNA) In Fibromyalgia Syndrome (FMS) Treated With Hyperbaric Oxigen Therapy (HOT) 165
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 165
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 157
123I-Ioflupane SPECT reduced parental glutathione (GSH) therapy evaluation in Parkinson’s disease (PD) 154
111In-pentetreotide SPECT/CT in neuroendocrine tumors (NETs) 154
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative local staging of primary breast cancer. 154
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 154
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative staging of breast cancer: a comparative study. 149
99mTc-Tetrofosmin scan in non small cell lung cancer (NSCLC) 147
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 146
Acute akinetic catatonia in multiple sclerosis: case report and review of literature 144
The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy 144
Role of an artificial neural network classifier, a classification tree (ClT), to diagnose Parkinson’s disease in early phase by using 123I-FP-CIT brain SPECT data. 140
123I-MIBG Cardiac Scintigraphy and123I-IOFLUPANE SPECT Combined Use In Uncertain Parkinsonian Syndromes 139
Combined 123I-Iofuplane SPECT and 123I-MIBG cardiac scintigraphy use in Parkinson disease(PD) and vascular Parkinsonism(VP) differential diagnosis. 138
The value of semiquantitative FDG-PET parameters in the diagnosis of solitary pulmonary nodules with pre-test intermediate likelihood of malignancy: a single-centre study 137
99mTc-Tetrofosmin axillary planar, SPECT and Pinhole SPECT (P-SPECT) in breast cancer (BC) non palpable lymph node metastases detection 136
18F-FDG PET/CT Usefulness In Primary Progressive Aphasia (PPA) Variants And In Fronto-Temporal Dementia (FTD) Or Alzheimer’s Disease (AD) Development. 135
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms 134
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 133
Neck iodine fixing foci in differentiated thyroid carcinoma (DTC) follow-up patients: a 131 I-SPECT/CT study. 133
The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging 132
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 132
The usefulness of SPECT/CT and neck pinhole SPECT (P-SPECT) as complementary tools to planar parathyroid scintigraphy in hyperparathyroidism (HPT). 132
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 131
99mTc-tetrofosmin SPECT/CT in solitary pulmonary nodule (SPN) evaluation. 131
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 128
Value of Shape and Texture Features from 18F-FDG PET/CT to Discriminate between Benign and Malignant Solitary Pulmonary Nodules: An Experimental Evaluation 127
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 127
123I-MIBG cardiac scintigraphy quantitative analysis in Parkinson’s disease (PD) and Parkinsonisms (P) differential diagnosis: a classification tree (CIT) classifier additional contribute. 126
The value of preoperative molecular breast imaging for the size assessment of invasive carcinoma and ductal carcinoma in situ 126
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 126
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 125
Brain 18F-FDG PET qualitative and quantitative analyses in Atypical Parkinsonian Syndromes (APS) with Cognitive Clinical Symptoms (CCS) 124
131I SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC). 123
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 123
The classification tree (CIT) classifier applied by 123I-MIBG cardiac scintigraphy in differentiating Parkinson’s disease (PD) from Parkinsonism (P). 122
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 122
Tc-99m Tetrofosmin (T) scintigraphy in patients with abdominal cancer 121
The role of Tc-99m Tetrofosmin (T) SPECT in mediastinal lymph node metastasis detection in lung cancer (LC). A.Spanu, F.Ginesu, A.Farris, M.E.Solinas, G.Deiola, C.Bagella, P.Pirina, G.C.Ginesu, S.Nuvoli, P.Solinas and G.Madeddu. Eur J Nucl Med 1997 121
123I-MIBG cardiac scintigraphy in discriminating Parkinson’s disease (PD) from vascular Parkinsonism (VP ) using classification tree( CIT ) classifier together with conventional quantitative analysis. 121
The usefulness of SPECT scintimammography in multifocal/multicentric breast cancer detection 120
Tc 99m-Tetrofosmin scan in lung and breast cancer detection 120
Breast scintigraphy with a breast specific gamma camera (BSGC) and dynamic breast magnetic resonance imaging (MRI) in the detection of primary breast cancer (BC): A comparative study 119
18F-FDG PET/CT in intracranial leptomeningeal carcinomatosis 119
Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 118
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 118
Plasma levels of leptin in heavy obese subjects 117
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 117
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 117
Caratterizzazione clinica del miocardio ibernato identificato mediante scintigrafia miocardica con Tallio-201. 116
Free/Total PSA ratio (F/T) and total (T) PSA combined use in monitoring finasteride (F) treated benign prostatic hyperplasia (BPH) 114
131I-SPECT/CT in differentiating neck iodine fixing foci in patients with differentiated thyroid carcinoma (DTC). 114
Anatomo-histopathological and histometric survey of venninous arteritis caused byStrongylus vulgarisin naturally infected horses in Sardinia (Italy) 114
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation 113
99mTc-Tetrofosmin (TF) mammoscintigraphy in primary breast cancer (BC) detection: SPECT vs Planar 113
Alzheimer disease (AD) and Lewy bodies dementia (LBD) differential diagnosis: a 123Ioflupane SPECT study. 113
Central nervous system involvement in systemic lupus erythematosus patients as revealed by brain MRI and SPECT. M.Piga, L.Satta, G. Sanna, G.L.Loi, M.Floris, A.Vacca, M.Laudadio, A.Careddu, C.Montaldo, A.Spanu, S.Nuvoli, G.Madeddu, A.Mathieu. Q J Nucl Med 1996, 40 (suppl 1): 18 113
131I-SPECT/CT usefulness in the follow up of patients thyroidectomized for thyroid papillary microcarcinoma ( PTMC). 113
Primary Progressive Aphasia (PPA) variants: a diagnostic brain 18F-FDG PET/CT study 113
A longitudinal study on bone metabolism in HIV patients treated with HAART. 112
131I-SPECT/CT in the diagnosis and characterization of metastatic lesions in patients with differentiated thyroid carcinoma (DTC) in chronic follow-up 112
Iodine-123 Ioflupano brain SPECT in extra-pyramidal movement disorders of recent appearance 111
The usefulness of high resolution planar scintimammography with dedicated breast camera in the diagnosis of multifocal/multicentric primary breast cancer (BC) 111
Scintimammography with dedicated breast camera vs SPECT in breast cancer and axillary lymph node metastasis detection: a preliminary study. 110
99mTc-tetrofosmin planar scintimammography and SPECT in monitoring the response to neoadjuvant hormone or chemotherapy in locally advanced primary breast cancer (LAPBC) 109
99mTc- tetrofosmin Breast Scintigraphy with breast-specific gamma-camera (BSGC) in breast cancer detection and preoperative local staging: a comparative study with dynamic Magnetic Resonance Imaging (MRI). 109
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 108
The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences 108
The role of TC-99m Tetrofosmin SPECT in breast cancer diagnosis, axillary lymph node staging and follow up 108
Impact of Lesion Delineation and Intensity Quantisation on the Stability of Texture Features from Lung Nodules on CT: A Reproducible Study 108
Beta-endorphin and Cortisol Levels in Plasma and CFS Following Acute Experimental Spinal Traumas 108
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative locl staging of primary breast cancer. 108
Totale 14.983
Categoria #
all - tutte 145.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.275


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.783 0 0 0 0 0 228 344 4 480 467 158 102
2021/20221.479 229 13 19 7 13 17 36 124 126 83 154 658
2022/20234.015 384 198 66 736 427 668 12 504 730 24 179 87
2023/20241.505 252 123 58 59 450 109 6 39 3 24 111 271
2024/202510.965 115 136 615 201 398 295 746 2.435 3.916 1.345 441 322
2025/202611.181 606 4.329 2.613 2.077 1.377 179 0 0 0 0 0 0
Totale 37.685